Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00591864 · ClinicalTrials.gov registry record · NA
Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT00591864: Completed NA study, sponsored by Mayo Clinic.
NCT00591864 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00591864, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the sensitivity of Molecular Breast Imaging (MBI) relative to MRI of the breast in patients undergoing MRI for a clinical concern, or abnormal diagnostic mammogram and/or ultrasound study.
Interventions
- DEVICE Molecular Breast Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00591864
The ClinicalTrials.gov registry entry for NCT00591864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular Breast Imaging is the first listed.
NCT00591864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00591864 about?
NCT00591864 is a clinical study titled "Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation". The purpose of this study is to determine the sensitivity of Molecular Breast Imaging (MBI) relative to MRI of the breast in patients undergoing MRI for a clinical concern, or abnormal diagnostic mammogram and/or ultrasound study.
What is the current status of trial NCT00591864?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2008-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00591864?
The interventions under investigation include: Molecular Breast Imaging (DEVICE).
Who is sponsoring clinical trial NCT00591864?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.